upgrad buy improv
outlook materi higher prior forecast
biggest debat ge pay compani asset past sever
year weak cash flow kept mani investor assign full multipl
core busi industri better forecast
overal industri driven power aviat importantli
guidanc industri exclud biopharma result follow
materi higher prior forecast
adjust time biopharma sale appear combin lower
expect drag aviat continu improv power lower corpor
expens confid execut upgrad buy neutral
appli higher multipl sum-of-the-part arriv po base
price object previous ev/ebitda multipl
industri estim assign neg valu ge capit
ev/ebitda would put compani line compar view
appropri given improv execut declin leverag
power aviat drive op beat capit posit
oper highlight quarter us solid beat power revenu
op ep beat welcom rel weak notabl ga
power servic grew aviat anoth contributor renew
continu drag haliade-x invest oper challeng
hydro grid
estim includ biopharma transact close expect ge
guid adjust ep forecast industri
would correspond exclud biopharma also plan adjust
estim follow confer call ge provid limit detail term
outlook detail provid outlook meet march
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
ge highli diversifi global industri
compani busi organ broadli
power renew aviat healthcar ge
capit compani product servic
engin medic equip wind turbin
other half busi tie servic
aftermarket support
believ ge signific cost cut
opportun new leadership note
compani undergon signific
reinvest cycl posit well
trajectori support share
us mn except per share data
base price object ev/ebitda multipl industri
estim assign neg valu ge capit ev/ebitda would
put compani line compar view appropri given
improv execut declin leverag
downsid risk po on-going end market pressur growth margin
power execut issu outsid power larger-than-expect capit
requir ge capit
andrew obin herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
